Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022
“Life science instrumentation market projected to grow at a CAGR of 6.7%”
The global life science instrumentation market is expected to reach USD 75.24 billion by 2022 from USD 54.49 million in 2017, at a CAGR of 6.7%. Increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are some of the key factors driving the growth of this market. However, the high cost of instruments and the dearth of skilled professionals are expected to restrain market growth to a certain extent.
“The spectroscopy segment is expected to dominate the global life science instrumentation market by technology during the forecast period”
By technology, the life science instrumentation market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The spectroscopy segment is expected to account for the largest share of the global life science instrumentation market in 2017 owing to the increasing use of spectroscopy instruments in the drug safety process. In addition, the increasing use of spectroscopy in combination with other technologies, such as chromatography, in various applications is also driving the growth of this market.
“The research applications segment is expected to dominate the global life science instrumentation market during the forecast period”
On the basis of application, the life science instrumentation market is segmented into research applications, clinical and diagnostic applications, and other applications. The research applications segment is expected to account for the largest share of the global life science instrumentation market in 2017 owing to launch of technologically advanced life science instruments for the drug discovery process, increasing research activities, growth in the number of preclinical and clinical trials, and increasing adoption of high-throughput life science instruments in drug development and drug discovery.
“Asia Pacific is projected to witness the highest growth during the forecast period “
While North America is expected to account for the largest share of the market in 2017, APAC is expected to register the highest growth rate during the forecast period (2017-2022). This is owing to the rising focus of key market players in emerging Asian countries; increasing crop research studies in Asia to feed its growing population; the growing pharmaceutical industry in India and China; the large biomedical industry in Singapore; and rising number of conferences, exhibitions, and meetings on analytical instruments across the region.
Breakdown of supply-side primary interviews: by company type, designation, and region:
By Company Type - Tier 1 –25%, Tier 2 –30% and Tier 3 –45%
By Designation – C level – 12%, Director level – 24%, Others – 64%
By Region – North America - 34%, Europe – 26%, APAC – 35%, RoW – 5%
The major players in the market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Hitachi High-Technologies Corporation (Japan), Eppendorf AG (Germany), QIAGEN N.V. (Netherlands), GE Healthcare (US), and Merck KGaA (Germany), among others.
This report studies the life science instrumentation market based on technology, applications, and end users. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
This research focuses on various levels of analysis—industry trends, vendor dive analysis of 25 market players, and company profiles of key 15 market players. This report also includes basic views on the competitive landscape, emerging and high-growth segments of the life science instrumentation market, high-growth regions and countries, and their respective drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on business strategies adopted by the major players in the life science instrumentation market. The report analyzes the life science instrumentation market by technology, application, end user, and region.
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the life science instrumentation market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various life science instrumentation products across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the life science instrumentation market.
Competitive Assessment: In-depth assessment of market shares, strategies, products distribution networks, and manufacturing capabilities of leading players in the life science instrumentation market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook